Xtant Medical Holdings, Inc. (XTNT)
USD 0.36
(-2.07%)
USD 0.36
(-2.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.15 Million USD | -50.38% |
| 2022 | -6.75 Million USD | -75.27% |
| 2021 | -3.85 Million USD | -413.18% |
| 2020 | -751 Thousand USD | 68.1% |
| 2019 | -2.35 Million USD | 96.08% |
| 2018 | -60.07 Million USD | -58.79% |
| 2017 | -37.83 Million USD | -401.43% |
| 2016 | -7.54 Million USD | 37.53% |
| 2015 | -12.07 Million USD | -92.8% |
| 2014 | -6.26 Million USD | 30.45% |
| 2013 | -9 Million USD | -82.17% |
| 2012 | -4.94 Million USD | 23.35% |
| 2011 | -6.45 Million USD | 25.12% |
| 2010 | -8.61 Million USD | -137.79% |
| 2009 | -3.62 Million USD | -22762.44% |
| 2008 | -15.84 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.47 Million USD | 8.83% |
| 2024 Q2 | -2.94 Million USD | 15.1% |
| 2023 Q3 | -3.38 Million USD | -143.35% |
| 2023 Q1 | -1.57 Million USD | 8.58% |
| 2023 Q2 | -1.39 Million USD | 11.74% |
| 2023 FY | -10.15 Million USD | -50.38% |
| 2023 Q4 | -3.8 Million USD | -12.44% |
| 2022 Q3 | -1.9 Million USD | -46.15% |
| 2022 Q4 | -1.72 Million USD | 9.26% |
| 2022 Q1 | -1.83 Million USD | 4.29% |
| 2022 FY | -6.75 Million USD | -75.27% |
| 2022 Q2 | -1.3 Million USD | 29.0% |
| 2021 Q2 | -491 Thousand USD | -9720.0% |
| 2021 FY | -3.85 Million USD | -413.18% |
| 2021 Q1 | -5000.00 USD | -102.08% |
| 2021 Q3 | -1.44 Million USD | -194.3% |
| 2021 Q4 | -1.91 Million USD | -32.39% |
| 2020 Q2 | -387 Thousand USD | 71.63% |
| 2020 FY | -751 Thousand USD | 68.1% |
| 2020 Q3 | 760 Thousand USD | 296.38% |
| 2020 Q4 | 240 Thousand USD | -68.42% |
| 2020 Q1 | -1.36 Million USD | -328.93% |
| 2019 Q2 | -563 Thousand USD | 15.72% |
| 2019 Q3 | -705 Thousand USD | -25.22% |
| 2019 FY | -2.35 Million USD | 96.08% |
| 2019 Q4 | -318 Thousand USD | 54.89% |
| 2019 Q1 | -668 Thousand USD | 98.78% |
| 2018 FY | -60.07 Million USD | -58.79% |
| 2018 Q4 | -54.72 Million USD | -3713.59% |
| 2018 Q3 | -1.43 Million USD | 36.53% |
| 2018 Q1 | -1.65 Million USD | 93.88% |
| 2018 Q2 | -2.26 Million USD | -36.45% |
| 2017 Q2 | -4.71 Million USD | -142.09% |
| 2017 FY | -37.83 Million USD | -401.43% |
| 2017 Q4 | -27.05 Million USD | -675.12% |
| 2017 Q3 | -3.49 Million USD | 26.01% |
| 2017 Q1 | -1.94 Million USD | -78.04% |
| 2016 FY | -7.54 Million USD | 37.53% |
| 2016 Q4 | -1.09 Million USD | 42.5% |
| 2016 Q3 | -1.9 Million USD | 10.31% |
| 2016 Q2 | -2.12 Million USD | 10.16% |
| 2016 Q1 | -2.36 Million USD | 42.06% |
| 2015 Q3 | -4.88 Million USD | -253.12% |
| 2015 Q4 | -4.07 Million USD | 16.53% |
| 2015 FY | -12.07 Million USD | -92.8% |
| 2015 Q1 | -1.73 Million USD | 30.43% |
| 2015 Q2 | -1.38 Million USD | 20.16% |
| 2014 Q2 | -1.33 Million USD | -11.75% |
| 2014 FY | -6.26 Million USD | 30.45% |
| 2014 Q4 | -2.49 Million USD | -99.17% |
| 2014 Q3 | -1.25 Million USD | 6.13% |
| 2014 Q1 | -1.19 Million USD | 66.51% |
| 2013 Q4 | -3.55 Million USD | -51.64% |
| 2013 FY | -9 Million USD | -82.17% |
| 2013 Q2 | -1.86 Million USD | -51.37% |
| 2013 Q1 | -1.23 Million USD | 65.13% |
| 2013 Q3 | -2.34 Million USD | -25.73% |
| 2012 FY | -4.94 Million USD | 23.35% |
| 2012 Q2 | -347.35 Thousand USD | 72.72% |
| 2012 Q1 | -1.27 Million USD | 52.29% |
| 2012 Q4 | -3.53 Million USD | -1762.7% |
| 2012 Q3 | 212.71 Thousand USD | 161.24% |
| 2011 Q1 | -1.93 Million USD | 51.82% |
| 2011 FY | -6.45 Million USD | 25.12% |
| 2011 Q2 | -279.99 Thousand USD | 85.54% |
| 2011 Q3 | -1.56 Million USD | -459.16% |
| 2011 Q4 | -2.66 Million USD | -70.44% |
| 2010 Q2 | -1.27 Million USD | -13739.79% |
| 2010 Q1 | -9228.00 USD | -8.23% |
| 2010 Q3 | -2.08 Million USD | -63.26% |
| 2010 FY | -8.61 Million USD | -137.79% |
| 2010 Q4 | -4.01 Million USD | -92.75% |
| 2009 Q4 | -8526.00 USD | -243.44% |
| 2009 Q3 | 5944.00 USD | 101.06% |
| 2009 FY | -3.62 Million USD | -22762.44% |
| 2009 Q2 | -562.74 Thousand USD | -5662.26% |
| 2009 Q1 | -9766.00 USD | 82.03% |
| 2008 FY | -15.84 Thousand USD | 0.0% |
| 2008 Q3 | 21.94 Thousand USD | 0.0% |
| 2008 Q4 | -54.35 Thousand USD | -347.7% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Electromed, Inc. | 6.58 Million USD | 254.353% |
| Myomo, Inc. | -8.23 Million USD | -23.403% |
| Senseonics Holdings, Inc. | -75.6 Million USD | 86.564% |
| Catheter Precision, Inc. | -78.11 Million USD | 86.997% |